Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Walter

Showing results (781-790 of 851) with videos related to

Pageof 86
Sort By:
British Journal of Cancer|May 17, 2007
Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trialP Kerbrat, H Roché, J Bonneterre, et al.
Blood|April 6, 2017
Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059Harriet S Walter, Sandrine Jayne, Simon A Rule, et al.
Plos Medicine|September 17, 2021
All-cause and cause-specific mortality during and following incarceration in Brazil: A retrospective cohort studyYiran E Liu, Everton Ferreira Lemos, Crhistinne Cavalheiro Maymone Gonçalves, et al.
British Journal of Haematology|October 15, 2024
The chromosomal translocation t(1;6)(p35.3;p25.2), recurrent in chronic lymphocytic leukaemia, leads to RCC1::IRF4 fusionSandrine Jayne, Cristina López, Natalie Put, et al.
BMC Cancer|June 12, 2022
Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trialA Wick, A Sander, M Koch, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2010
Structure-activity relationships and in vivo activity of (1H-pyrazol-4-yl)acetamide antagonists of the P2X(7) receptorPaul J Beswick, Andy Billinton, Laura J Chambers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancerS Giacchetti, B Perpoint, R Zidani, et al.
Science Advances|June 5, 2026
Structural and functional mapping of protective human monoclonal antibodies against enterovirus A71Daming Zhou, Abhay Kotecha, James T Kelly, et al.
Nature Structural & Molecular Biology|February 11, 2014
More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding moleculesLuigi De Colibus, Xiangxi Wang, John A B Spyrou, et al.
Nature Communications|June 4, 2013
Picornavirus uncoating intermediate captured in atomic detailJingshan Ren, Xiangxi Wang, Zhongyu Hu, et al.
Pageof 86

Showing results (781-790 of 851) with videos related to

Sort By:
Pageof 86
British Journal of Cancer|May 17, 2007
Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trialP Kerbrat, H Roché, J Bonneterre, et al.
Blood|April 6, 2017
Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059Harriet S Walter, Sandrine Jayne, Simon A Rule, et al.
Plos Medicine|September 17, 2021
All-cause and cause-specific mortality during and following incarceration in Brazil: A retrospective cohort studyYiran E Liu, Everton Ferreira Lemos, Crhistinne Cavalheiro Maymone Gonçalves, et al.
British Journal of Haematology|October 15, 2024
The chromosomal translocation t(1;6)(p35.3;p25.2), recurrent in chronic lymphocytic leukaemia, leads to RCC1::IRF4 fusionSandrine Jayne, Cristina López, Natalie Put, et al.
BMC Cancer|June 12, 2022
Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trialA Wick, A Sander, M Koch, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2010
Structure-activity relationships and in vivo activity of (1H-pyrazol-4-yl)acetamide antagonists of the P2X(7) receptorPaul J Beswick, Andy Billinton, Laura J Chambers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancerS Giacchetti, B Perpoint, R Zidani, et al.
Science Advances|June 5, 2026
Structural and functional mapping of protective human monoclonal antibodies against enterovirus A71Daming Zhou, Abhay Kotecha, James T Kelly, et al.
Nature Structural & Molecular Biology|February 11, 2014
More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding moleculesLuigi De Colibus, Xiangxi Wang, John A B Spyrou, et al.
Nature Communications|June 4, 2013
Picornavirus uncoating intermediate captured in atomic detailJingshan Ren, Xiangxi Wang, Zhongyu Hu, et al.
Pageof 86